Myeloid derived suppressors cells (MDSC) play major roles in regulating immune
homeostasis and immune responses in many conditions, including cancer. MDSC interact …

Despite the wide variety of existing therapies, multiple myeloma (MM) remains a disease
with dismal prognosis. Choosing the right treatment for each patient remains one of the …

Based on the results of epidemiological and preclinical studies, metformin can improve the
prognosis of patients with malignant tumors. Studies have confirmed that metformin inhibits …

Multiple myeloma (MM) is a plasma cell dyscrasia characterized by the clonal proliferation of
antibody producing plasma cells. Despite the use of next generation proteasome inhibitors …

The mechanisms underlying the functional impairment and metabolic reprogramming of T
lymphocytes in multiple myeloma (MM) have not been fully elucidated. In this study, single …

Multiple myeloma (MM) is the second most common hematological malignancy worldwide,
characterized by abnormal proliferation of malignant plasma cells within a tumor-permissive …

Multiple myeloma (MM) is the second most common haematological malignancy and
remains incurable despite therapeutic advances. 18F-FDG (FDG) PET/CT is a relevant tool …

In the era of personalized medicine greatly improved by molecular diagnosis and tailor-
made therapies, the survival rate of acute myeloid leukemia (AML) at 5 years remains …

Purpose The aim of this study was to compare [18F] FDG and [68Ga] Ga-PSMA-11 PET/CT
image findings in patients with multiple myeloma (MM). Methods Twenty consecutive …

Ferroptosis is a kind of iron-dependent programmed cell death discovered in recent years.
Its main feature is the accumulation of lipid reactive oxygen species in cells, eventually …